Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 78 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019Treatment of type 2 diabetes with the designer cytokine IC7FcFindeisen, M.; Allen, T.L.; Henstridge, D.C.; Kammoun, H.; Brandon, A.E.; Baggio, L.L.; Watt, K.I.; Pal, M.; Cron, L.; Estevez, E.; Yang, C.; Kowalski, G.M.; O'Reilly, L.; Egan, C.; Sun, E.; Thai, L.M.; Krippner, G.; Adams, T.E.; Lee, R.S.; Grötzinger, J.; et al.
2019A divergent transcriptional landscape underpins the development and functional branching of MAIT cellsKoay, H.-F.; Su, S.; Amann-Zalcenstein, D.; Daley, S.R.; Comerford, I.; Miosge, L.; Whyte, C.E.; Konstantinov, I.E.; d'Udekem, Y.; Baldwin, T.; Hickey, P.F.; Berzins, S.P.; Mak, J.Y.W.; Sontani, Y.; Roots, C.M.; Sidwell, T.; Kallies, A.; Chen, Z.; Nüssing, S.; Kedzierska, K.; et al.
2013A novel prion disease associated with diarrhea and autonomic neuropathyMead, S.; Gandhi, S.; Beck, J.; Caine, D.; Gallujipali, D.; Carswell, C.; Hyare, H.; Joiner, S.; Ayling, H.; Lashley, T.; Linehan, J.M.; Al-Doujaily, H.; Sharps, B.; Revesz, T.; Sandberg, M.K.; Reilly, M.M.; Koltzenburg, M.; Forbes, A.; Rudge, P.; Brandner, S.; et al.
2019Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemiaMoujalled, D.M.; Pomilio, G.; Ghiurau, C.; Ivey, A.; Salmon, J.; Rijal, S.; Macraild, S.; Zhang, L.; Teh, T.C.; Tiong, I.S.; Lan, P.; Chanrion, M.; Claperon, A.; Rocchetti, F.; Zichi, A.; Kraus-Berthier, L.; Wang, Y.; Halilovic, E.; Morris, E.; Colland, F.; et al.
2015Avian influenza in Australia: a summary of 5 years of wild bird surveillanceGrillo, V.L.; Arzey, K.E.; Hansbro, P.M.; Hurt, A.C.; Warner, S.; Bergfeld, J.; Burgess, G.W.; Cookson, B.; Dickason, C.J.; Ferenczi, M.; Hollingsworth, T.; Hoque, M.; Jackson, R.B.; Klaassen, M.; Kirkland, P.D.; Kung, N.Y.; Lisovski, S.; O'Dea, M.A.; O'Riley, K.; Roshier, D.; et al.
2015A new antibiotic with potent activity targets MscLIscla, I.; Wray, R.; Blount, P.; Larkins-Ford, J.; Conery, A.; Ausubel, F.; Ramu, S.; Kavanagh, A.; Huang, J.; Blaskovich, M.; Cooper, M.; Obregon-Henao, A.; Orme, I.; Tjandra, E.; Stroeher, U.; Brown, M.; Macardle, C.; van Holst Pellekaan, N.; Ling Tong, C.; Slattery, A.; et al.
2015p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseYao, X.Q.; Jiao, S.S.; Saadipour, K.; Zeng, F.; Wang, Q.H.; Zhu, C.; Shen, L.L.; Zeng, G.H.; Liang, C.R.; Wang, J.; Liu, Y.H.; Hou, H.Y.; Xu, X.; Su, Y.P.; Fan, X.T.; Xiao, H.L.; Lue, L.F.; Zeng, Y.Q.; Giunta, B.; Zhong, J.H.; et al.
2015Copy number variants in patients with intellectual disability affect the regulation of ARX transcription factor geneIshibashi, M.; Manning, E.; Shoubridge, C.; Krecsmarik, M.; Hawkins, T.; Giacomotto, J.; Zhao, T.; Mueller, T.; Bader, P.; Cheung, S.; Stankiewicz, P.; Bain, N.; Hackett, A.; Reddy, C.; Mechaly, A.; Peers, B.; Wilson, S.; Lenhard, B.; Bally-Cuif, L.; Gecz, J.; et al.
2016Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic targetAsim, M.; Massie, C.; Orafidiya, F.; Pértega-Gomes, N.; Warren, A.; Esmaeili, M.; Selth, L.; Zecchini, H.; Luko, K.; Qureshi, A.; Baridi, A.; Menon, S.; Madhu, B.; Escriu, C.; Lyons, S.; Vowler, S.; Zecchini, V.; Shaw, G.; Hessenkemper, W.; Russell, R.; et al.
2013Identification Of KLHL41 mutations implicates BTB-Kelch-Mediated Ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathyGupta, V.; Ravenscroft, G.; Shaheen, R.; Todd, E.; Swanson, L.; Shiina, M.; Ogata, K.; Hsu, C.; Clarke, N.; Darras, B.; Farrar, M.; Hashem, A.; Manton, N.; Muntoni, F.; North, K.; Sandaradura, S.; Nishino, I.; Hayashi, Y.; Sewry, C.; Thompson, E.; et al.